Alloway Paul 4
4 · Homology Medicines, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Alloway Paul
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-01-01+4,420→ 21,126 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−8,910→ 18,090 total→ Common Stock (8,910 underlying) - Exercise/Conversion
Restricted Stock Units
2024-01-01−5,280→ 5,440 total→ Common Stock (5,280 underlying) - Exercise/Conversion
Common Stock
2024-01-01+5,280→ 26,406 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−4,420→ 0 total→ Common Stock (4,420 underlying) - Exercise/Conversion
Common Stock
2024-01-01+8,910→ 35,316 total
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.
- [F3]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date.
- [F4]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.